Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|July 17, 2026
Analysis of Serious Breach Cases Reported in the EU Clinical Trials Information System: Quantitative and Qualitative AssessmentEwelina Wodnicka, Damian Swieczkowski
Psychiatry Research|December 16, 2025
Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 8, 2025
Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: A systematic review of early-phase clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Therapeutic Advances in Psychopharmacology|July 2, 2026
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysisDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Acta Poloniae Pharmaceutica|March 8, 2018
PHARMACEUTICAL CARE IN OPINION OF POLISH MEDICAL AND PHARMACEUTICAL STUDENTS: AN EXPLORATORY STUDYDamian Swieczkowski, Piotr Merks, Milosz Jaguszewski, et al.
Pneumonologia I Alergologia Polska|July 21, 2016
The pharmaceutical care in asthma - Polish and global perspectiveDamian Swieczkowski, Patryk Poniatowski, Piotr Merks, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 17, 2026
Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocolsDamian Swieczkowski, Aleksander Kwaśny, Krzysztof Sadko, et al.
Journal of Psychoactive Drugs|April 19, 2025
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical TrialsDamian Swieczkowski, Aleksander Kwaśny, Krzysztof Sadko, et al.
International Journal of Cardiology|August 7, 2016
Pharmaceutical services as a tool to improve outcomes in patients with cardiovascular diseasesDamian Swieczkowski, Mariusz Mogielnicki, Piotr Merks, et al.
International Journal of Psychiatry in Clinical Practice|February 12, 2026
Addressing diversity gaps in esketamine clinical trials: a registry-based cross-sectional analysis of sex, race and ethnicityDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
Pageof 4